Search for: "U.S. v. Earl*" Results 321 - 340 of 22,344
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2007, 11:07 am
The following is an analysis, written by Sarah Rispin of Akin Gump's Washington, DC office, of the case U.S. v. [read post]
14 Feb 2019, 9:50 pm by Patent Docs
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
19 May 2015, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit affirmed a decision by the U.S. [read post]
9 Sep 2020, 9:59 pm by Patent Docs
By Donald Zuhn -- Earlier today, the Federal Circuit vacated the final written decision by the U.S. [read post]
27 Jul 2016, 9:18 pm by Patent Docs
Noonan -- The Federal Circuit affirmed the decision by the Patent Trial and Appeals Board (PTAB) in an inter partes review (IPR) that the claims of Genzyme's U.S Patent Nos. 7,351,410 and 7,655,226 were obvious, in Genzyme Therapeutic Products, Inc. v. [read post]
9 Jun 2008, 7:20 pm
Philip Morris, this time to decide whether the Oregon courts complied with the U.S. [read post]